Abstract:Previously, we have reported that siRNA-mediated survivin inhibition could enhance in vitro chemo- or radiosensitivity of colorectal cancer (CRC) cells. The aim of this study was to investigate whether that small interfering RNA (siRNA) targeting survivin could enhance in vivo chemo- or radiosensitivity of colorectal cancer cells.pSilencer4.1-shRNA targeting survivin (pSilencer4.1-s) and pSilencer4.1-NC (negative control) vectors were previously constructed by us. Two colorectal cancer cell lines (LoVo or HCT-8) were collected and used for forming subcutaneous tumors in nude mice. Then, the tumors were intratumorally injected with pSilencer4.1-s or pSilencer4.1-NC vectors combined with chemotherapy (5-FU) or radiotherapy (6Gy). Firstly, the expression of survivin mRNA and protein in tumors treated with pSilencer4.1-s or pSilencer4.1-NC alone was detected by RT-PCR and Western blotting or immunohistochemistry assays. Next, the tumor volumes were recorded. The terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay was performed to detect apoptosis of tumor cells and the activity of caspase-3 was detected.The expression of survivin mRNA and protein in tumor tissues treated with pSilencer4.1-s was significantly downregulated (p < 0.05). The immunostaining of survivin protein was also significantly weaker in tumor tissues treated with pSilencer4.1-s. Moreover, the volumes of the nude mice treated with pSilencer4.1-s and chemo- or radiotherapy decreased markedly compared with those of the mock- or pSilencer4.1NC-treated control combined with chemo- or radiotherapy. The apoptosis of tumor tissue cells treated with pSilencer4.1-s and chemo- or radiotherapy could be significantly increased compared with the mock- or pSilencer4.1-NC-treated control combined with chemo- or radiotherapy (p < 0.05), which might be associated with the active Caspase-3 pathway.siRNA-mediated survivin inhibition could enhance in vivo chemo- or radiosensitivity of CRC cells. Accordingly, the survivin gene might be a potential target for the chemoradiotherapy of CRC.

Survivin Downregulation By Sirna/Cationic Liposome Complex Radiosensitises Human Hepatoma Cells In Vitro And In Vivo

Survivin As a Factor of Radioresistance to High-Let Carbon Ions in Human Hepatoma SMMC.7721 Cells

Silencing Survivin Gene Enhances Radio-Sensitivity of Human Hepatoma SMMC-7721

siRNA targeting survivin inhibits the growth and enhances the chemosensitivity of hepatocellular carcinoma cells.

Rna Interference-Mediated Inhibition of Endogenous Survivin Expression in Hepatocarcinoma Cell

Downregulation of Survivin by Shrna Inhibits Invasion and Enhances the Radiosensitivity of Laryngeal Squamous Cell Carcinoma

Anti-tumor Effect of RNA Interference Silencing Survivin Gene Combined with X-ray Irradiation on Human Hepatoma Xenograft in Nude Mice

Anti-tumor Effect of Silencing HIF-lα and Survivin Genes Combined with Radiotherapy on Human Hepatoma Xenograft in Nude Mice

Experimental study on the effects of siRNA targeting survivin combined with radiotherapy on human carcinoma cells SW480

Anti-Tumor Effect Of Rna Interference Silencing Hif-1 Alpha And Survivin Genes Combined With X-Rays Irradiation On Human Hepatoma Xenograft In Nude Mice

[Effect of Sirna Targeted Against Survivin on the Malignant Behaviors of Human Hepatoma Cells].

Effect of enhancing the radiosensitivity of pancreatic cancer cell line PC-2 by siRNA against Survivin.

Down-regulation of survivin expression by small interfering RNA induces pancreatic cancer cell apoptosis and enhances its radiosensitivity.

siRNA targeting survivin inhibits growth and induces apoptosis in human renal clear cell carcinoma 786-O cells.

Survivin Knockdown by Short Hairpin RNA Abrogates the Growth of Human Hepatocellular Carcinoma Xenografts in Nude Mice.

siRNA targeting survivin induces sensitization of hepatocarcinoma cells to tumor necrosis factor related apoptosis-inducing ligand

Down Regulation of Survivin Gene and Up Regulation of P53 Gene Expression by Sirna Induces Apoptosis in Human Hepatocellular Carcinoma Cell Line HepG2

SiRNA-mediated Survivin Inhibition Enhances Chemo- or Radiosensivity of Colorectal Cancer Cells in Tumor-Bearing Nude Mice.

Enhancement of Cisplatin Sensitivity in Lung Cancer Xenografts by Liposome-Mediated Delivery of the Plasmid Expressing Small Hairpin RNA Targeting Survivin.

Enhancement of Cancer Cell Radiosensitivity by Adenovirus Vector Carrying Sirna of Survivin Gene

Improved Radiotherapy by Survivin Small Hairpin RNA Trigger Apoptosis of Human Lung Adenocarcinoma Via Caspase-3 Upregulation in Vitro and in Vivo